Biotech WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics April 23, 2026
Biotech Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain April 22, 2026
Biotech Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer April 21, 2026
Biotech New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore April 20, 2026
Biotech 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood April 19, 2026
Biotech Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026 April 18, 2026
Biotech Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules April 17, 2026
Biotech Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline April 14, 2026